4 results
Heparin, Fondaparinux, and Novel Oral Anticoagulants - Pathophysiology

Anticoagulation with parenteral (intravenous or subcutaneous) and oral anticoagulants
, LMWH, or fondaparinux ... (UFH): Inhibits ... #Heparins #LMWH ... #UFH #DOAC #Dabigatran ... NOAC #Mechanism
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
direct-acting oral anticoagulants ... filtration rate; DOAC ... direct-acting oral anticoagulant ... #DOAC #VTE #Malignancy ... #Management #Hematology
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
consider withholding anticoagulant ... DOAC, direct oral ... anticoagulant; ... #DOAC #VTE #Malignancy ... #Management #Hematology
The coagulation cascade is shown, separated into different phases with their endogenous and pharmacological inhibitors shown.
#pathophysiology ... #anticoagulation ... #anticoagulant ... #Warfarin #Dabigatran ... #Edoxaban #heparin